166 related articles for article (PubMed ID: 34630701)
1. Value of GastroPanel in the diagnosis of atrophic gastritis.
Grad C; Pop A; Gaborean E; Grad S; Dumitrascu D
Exp Ther Med; 2021 Nov; 22(5):1347. PubMed ID: 34630701
[TBL] [Abstract][Full Text] [Related]
2. Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer.
De Re V; Orzes E; Canzonieri V; Maiero S; Fornasarig M; Alessandrini L; Cervo S; Steffan A; Zanette G; Mazzon C; De Paoli P; Cannizzaro R
Clin Transl Gastroenterol; 2016 Jul; 7(7):e183. PubMed ID: 27441820
[TBL] [Abstract][Full Text] [Related]
3. GastroPanel® test for non-invasive diagnosis of atrophic gastritis in patients with dyspepsia.
Masci E; Pellicano R; Mangiavillano B; Luigiano C; Stelitano L; Morace C; Viale E; Freschi M; Locatelli M; Ieri R; Cavallaro A; Testoni S; Testoni PA
Minerva Gastroenterol Dietol; 2014 Mar; 60(1):79-83. PubMed ID: 24632770
[TBL] [Abstract][Full Text] [Related]
4. Value of Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and
Sivandzadeh GR; Zadeh Fard SA; Zahmatkesh A; Anbardar MH; Lankarani KB
Middle East J Dig Dis; 2023 Jan; 15(1):37-44. PubMed ID: 37547155
[No Abstract] [Full Text] [Related]
5. Accuracy of GastroPanel for the diagnosis of atrophic gastritis.
McNicholl AG; Forné M; Barrio J; De la Coba C; González B; Rivera R; Esteve M; Fernandez-Bañares F; Madrigal B; Gras-Miralles B; Perez-Aisa A; Viver-Pi-Sunyer JM; Bory F; Rosinach M; Loras C; Esteban C; Santolaria S; Gomollon F; Valle J; Gisbert JP;
Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):941-8. PubMed ID: 25014624
[TBL] [Abstract][Full Text] [Related]
6. A panel of stomach-specific biomarkers (GastroPanel®) for the diagnosis of atrophic gastritis: A prospective, multicenter study in a low gastric cancer incidence area.
Chapelle N; Petryszyn P; Blin J; Leroy M; Le Berre-Scoul C; Jirka I; Neunlist M; Moussata D; Lamarque D; Olivier R; Tougeron D; Mosnier JF; Matysiak-Budnik T
Helicobacter; 2020 Oct; 25(5):e12727. PubMed ID: 32700438
[TBL] [Abstract][Full Text] [Related]
7. Serological assessment of gastric mucosal atrophy in gastric cancer.
Bornschein J; Selgrad M; Wex T; Kuester D; Malfertheiner P
BMC Gastroenterol; 2012 Jan; 12():10. PubMed ID: 22289789
[TBL] [Abstract][Full Text] [Related]
8. Invasive and non-invasive diagnosis of Helicobacter pylori-associated atrophic gastritis: a comparative study.
Pasechnikov VD; Chukov SZ; Kotelevets SM; Mostovov AN; Mernova VP; Polyakova MB
Scand J Gastroenterol; 2005 Mar; 40(3):297-301. PubMed ID: 15932170
[TBL] [Abstract][Full Text] [Related]
9.
MÄki M; SÖderstrÖm D; Paloheimo L; Hendolin P; Suovaniemi O; SyrjÄnen K
Anticancer Res; 2020 Nov; 40(11):6387-6398. PubMed ID: 33109577
[TBL] [Abstract][Full Text] [Related]
10. [Serological diagnosis of atrophic gastritis with a combination of pepsinogen I and II, gastrin-17 and anti-Helicobacter pylori antibodies].
Valle Muñoz J; Artaza Varasa T; López Pardo R; Rodríguez Merlo R; Pérez Grueso MJ; Martín Escobedo R; Alcántara Torres M; Cuena Boy R; Carrobles Jiménez JM
Gastroenterol Hepatol; 2007 Dec; 30(10):567-71. PubMed ID: 18028850
[TBL] [Abstract][Full Text] [Related]
11. HELICOBACTER PYLORI CHRONIC GASTRITIS ON PATIENTS WITH PREMALIGNANT CONDITIONS: OLGA AND OLGIM EVALUATION AND SERUM BIOMARKERS PERFORMANCE.
Coelho MCF; Ribeiro HG; Gomes CGO; Marinho FP; Barbosa AJA; Coelho LGV
Arq Gastroenterol; 2021; 58(1):39-47. PubMed ID: 33909795
[TBL] [Abstract][Full Text] [Related]
12. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study.
Väänänen H; Vauhkonen M; Helske T; Kääriäinen I; Rasmussen M; Tunturi-Hihnala H; Koskenpato J; Sotka M; Turunen M; Sandström R; Ristikankare M; Jussila A; Sipponen P
Eur J Gastroenterol Hepatol; 2003 Aug; 15(8):885-91. PubMed ID: 12867799
[TBL] [Abstract][Full Text] [Related]
13. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
14. DIAGNOSTIC ACCURACY OF GASTROPANEL® FOR ATROPHIC GASTRITIS IN BRAZILIAN SUBJECTS AND THE EFFECT OF PROTON PUMP INHIBITORS.
Mattar R; Marques SB; Ribeiro IB; Visconti TAC; Funari M; DE Moura EGH
Arq Gastroenterol; 2020; 57(2):154-160. PubMed ID: 32609157
[TBL] [Abstract][Full Text] [Related]
15. [Importance of biologic parameters in Helicobacter pylori gastritis: comparison with histological results].
Abaza H; Ghanem A; Karoui J; Jmal A; Dhouib R; Harzallah L; Ben Mami N; Khaled R; Guemira F
Ann Biol Clin (Paris); 2010; 68(4):473-9. PubMed ID: 20650743
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of atrophic gastritis in dyspeptic patients in Piedmont. A survey using the GastroPanel test.
Lombardo L; Leto R; Molinaro G; Migliardi M; Ravarino N; Rocca R; Torchio B
Clin Chem Lab Med; 2010 Sep; 48(9):1327-32. PubMed ID: 20604730
[TBL] [Abstract][Full Text] [Related]
17. Is GastroPanel serum assay useful in the diagnosis of Helicobacter pylori infection and associated gastritis in children?
Koivusalo AI; Pakarinen MP; Kolho KL
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):35-8. PubMed ID: 16949782
[TBL] [Abstract][Full Text] [Related]
18. GastroPanel® Biomarker Assay: The Most Comprehensive Test for
Syrjänen K; Eskelinen M; Peetsalu A; Sillakivi T; Sipponen P; Härkönen M; Paloheimo L; Mäki M; Tiusanen T; Suovaniemi O; DiMARIO F; Fan ZP
Anticancer Res; 2019 Mar; 39(3):1091-1104. PubMed ID: 30842138
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel®) in St. Petersburg.
Roman LD; Lukyanchuk R; Sablin OA; Araslanova EI; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
Anticancer Res; 2016 Aug; 36(8):4129-38. PubMed ID: 27466521
[TBL] [Abstract][Full Text] [Related]
20. Non-endoscopic diagnosis of multifocal atrophic gastritis; efficacy of serum gastrin-17, pepsinogens and Helicobacter pylori antibodies.
Hartleb M; Wandzel P; Waluga M; Matyszczyk B; Bołdys H; Romañczyk T
Acta Gastroenterol Belg; 2004; 67(4):320-6. PubMed ID: 15727075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]